Vimarsana
Biggest News Aggregation in the World

Page 8 - Steve Bernstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steve Bernstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steve Bernstein Today - Breaking & Trending Today

Trump Finally Cements Control Over Rogue Labor Board - Vimarsana News

Trump Finally Cements Control Over Rogue Labor Board

Following the eight disastrous years of Democrat’s perverse anti-job agenda at the National Labor Relations Board (NLRB), Republicans are now busy cleaning out the accumulated filth of the Obama Administration. Following the conformation of a new top prosecutor, Republican Peter Robb, there is truly a “new sheriff” in town. “Not only is the general counsel […]

Labor ruling will embolden unions to pursue nursing home cases: experts - Vimarsana News

Labor ruling will embolden unions to pursue nursing home cases: experts

A federal ruling could give unions more leverage in negotiations and organizing campaigns, attorneys said. 

FDA to Review Abecma for Earlier Myeloma Treatment - Vimarsana News

FDA to Review Abecma for Earlier Myeloma Treatment

The FDA has accepted a supplemental Biologics License Application for moving up the use of Abecma, a CAR-T cell therapy, for adult patients with multiple myeloma.

Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults with Triple-Class Exposed Relapsed and/or Refractory Multiple Myeloma - Vimarsana News

Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults with Triple-Class Exposed Relapsed and/or Refractory Multiple Myeloma

U.S. FDA accepted Bristol Myers Squibb and 2seventy bio’s supplemental Biologics License Application and has assigned a target action date of December 16, 2023 European Medicines Agency has... | April 17, 2023

Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults - Vimarsana News

Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults

U.S. FDA accepted Bristol Myers Squibb and 2seventy bio’s supplemental Biologics License Application and has assigned a target action date of December 16, 2023European Medicines Agency has validated Bristol Myers Squibb’s Type II variation application for AbecmaBristol Myers Squibb’s supplemental New Drug Applicatio...